Telbivudine globe trial at year two: Efficacy, safety, and predictors of outcome in patients with chronic hepatitis B

被引：0
|
作者：
Han, Steven-Huy
Lai, Ching Lung
Gane, Edward J.
Liaw, Yun-Fan
Thongsawar, Satawat
Wang, Yuming
Chen, Yagang
Heathcote, E. Jenny
Rasenack, Jens
Bzowej, Natalie
Naoumov, Nikolai V.
Brown, Nathaniel A.
机构：
来源：
GASTROENTEROLOGY | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A765 / A765
页数：1
相关论文
共 50 条
  • [41] Predictors of Response to Entecavir in Chronic Hepatitis B Patients With Incomplete Virologic Response to Telbivudine in a Four-Year Prospective Cohort
    Lo, Angeline Oi-Shan
    Wong, Vincent W.
    Wong, Grace
    Chan, Hoi-Yun
    Chan, Henry Lik-Yuen
    GASTROENTEROLOGY, 2012, 142 (05) : S988 - S989
  • [42] EFFICACY OF 3 YEARS OF TELBIVUDINE TREATMENT FOR PATIENTS WITH GENOTYPE B/C CHRONIC HEPATITIS B (CHB)
    Chen, Y. -C.
    Hsu, C. -W
    Liaw, Y. -F
    Jia, J.
    Leung, N.
    Hou, J.
    Wang, Y.
    Chen, Y.
    Niu, J.
    Wei, L. L.
    Zhou, X. -Q.
    Bao, W.
    Lopez, P.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S329 - S329
  • [43] Correction to: Safety and efficacy of lamivudine or telbivudine started in early pregnancy for mothers with active chronic hepatitis B
    Tianyu He
    Yuqing Bai
    Haodong Cai
    Xiaojuan Ou
    Min Liu
    Wei Yi
    Jidong Jia
    Hepatology International, 2018, 12 : 289 - 289
  • [44] 2-YEAR RESULTS OF TELBIVUDINE (LDT) ROADMAP STUDY VERIFY THE OPTIMAL EFFICACY AND SAFETY RESULTS IN HBEAG POSITIVE CHRONIC HEPATITIS B (CHB) PATIENTS
    Piratvisuth, T.
    Komolmit, P.
    Tanwandee, T.
    Sukeepaisarnjaroen, W.
    Chan, H. L.
    Pessoa, M. G.
    Fassio, E.
    Ono-Nita, S.
    Bessone, F.
    Daruich, J.
    Zeuzem, S.
    Cheinquer, H.
    Dong, Y.
    Trylesinski, A.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S214 - S214
  • [45] Telbivudine Improves the Outcome in Patients with Acute-on-Chronic Hepatitis B Liver Failure.
    Zhang, Yimin
    Yang, Yida
    Huang, Jianrong
    Jia, Hongyu
    Li, Lanjuan
    LIVER TRANSPLANTATION, 2013, 19 : S124 - S124
  • [46] Efficacy and Safety of Telbivudine Compared to Entecavir Among HBeAg plus Chronic Hepatitis B Patients: a Meta-Analysis Study
    Liang, Jian
    Jiang, Man Jun
    Deng, Xin
    Zhou, Xiao Xiao
    HEPATITIS MONTHLY, 2013, 13 (06)
  • [47] Telbivudine displays consistent antiviral efficacy across patient subgroups for the treatment of chronic hepatitis B: Results from the GLOBE study
    Thongsawat, S.
    Lai, C. L.
    Gane, E.
    Chao, G.
    Fielman, B.
    Brown, N.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S49 - S49
  • [48] Telbivudine displays consistent antiviral efficacy across patient subgroups for the treatment of chronic hepatitis B: results from the globe study
    Lai, Ching. Lung
    Gane, Edward
    Liaw, Yun Fan
    Thongsawat, Satawat
    Chen, Yagang
    Lu, Wei-Lun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A28 - A29
  • [49] Results of a one-year international phase IIB comparative trial of telbivudine, lamivudine, and the combination, in patients with chronic hepatitis B
    Lai, CL
    Leung, NWY
    Teo, EK
    Tong, M
    Wong, F
    Hann, HW
    Han, S
    Poynard, T
    Myers, M
    Chao, G
    Lloyd, D
    Brown, N
    HEPATOLOGY, 2003, 38 (04) : 262A - 262A
  • [50] Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial
    Hou, Jinlin
    Yin, You-Kuan
    Xu, Daozhen
    Tan, Deming
    Niu, Junqi
    Zhou, Xiaqiu
    Wang, Yuming
    Zhu, Limin
    He, Yongwen
    Ren, Hong
    Wan, Mobin
    Chen, Chengwei
    Wu, Shanming
    Chen, Yagang
    Xu, Jiazhang
    Wang, Qinhuan
    Wei, Lai
    Chao, George
    Constance, Barbara Fielman
    Harb, George
    Brown, Nathaniel A.
    Jia, Jidong
    HEPATOLOGY, 2008, 47 (02) : 447 - 454
12345